Learn More
Medchemexpress LLC MK-8245 Trifluoroacetate | 1415559-41-9 | 98.5% | 1 MG

Supplier: Medchemexpress LLC HY130771MG
MK-8245 trifluoroacetate is a liver-targeting inhibitor of stearoyl-CoA desaturase (SCD) with anti-diabetic and anti-dyslipidemic efficacy. It demonstrates high potency with an IC50 of 1 nM for human SCD1 and 3 nM for rat and mouse SCD1, and selectively targets Δ-5 and Δ-6 desaturases. Its tetrazole acetic acid moiety facilitates OATPs recognition and liver-targeting.
- Liver-targeting inhibitor of stearoyl-CoA desaturase (SCD)
- Potent inhibition with IC50 of 1 nM for human SCD1
- Shows anti-diabetic and anti-dyslipidemic efficacy
- Tetrazole acetic acid moiety aids OATPs recognition and liver-targeting
- Exhibits significant SCD inhibition in rat hepatocyte assay (IC50 of 68 nM)
- Displays highly selective activity for Δ-5 and Δ-6 desaturases
- Concentrated in the liver in vivo, with low exposure in other tissues
- Improves glucose clearance in eDIO mice
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.